as on October 14, 2025 at 1:29 am IST
Day's Low
Day's High
0.92%
Downside
2.30%
Upside
52 Week's Low
52 Week's High
14.21%
Downside
55.76%
Upside
Check Mimedx Group, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$969.1M
EPS (TTM)
0.325
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.50%
PE Ratio (TTM)
31.19
Industry PE ratio
-0.32286624203821657
PEG Ratio
2.97
EBITDA
53.7M
Revenue (TTM)
363.8M
Profit Margin
8.84%
Return On Equity TTM
16.61%
Track how Mimedx Group, Inc. P/E has moved over time to understand its valuation trends.
Mimedx Group, Inc. in the last 5 years
Lowest (-161.05x)
March 31, 2021
Industry (-0.32x)
October 14, 2025
Today (31.19x)
October 14, 2025
Highest (31.60x)
September 30, 2025
Today’s Price to Earnings Ratio: 31.19x
Compare market cap, revenue, PE, and other key metrics of Mimedx Group, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $969.1M | NA | 31.19 | 8.84% | |
BUY | $60.3B | 223.08% | -505.15 | -12.96% | |
NA | $37.8B | NA | NA | -3.89% | |
BUY | $104.6B | 50.07% | 28.98 | 31.86% | |
BUY | $59.8B | -7.17% | 14.23 | 31.37% |
The Mimedx Group, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Mimedx Group, Inc. investment value today
Current value as on today
₹1,19,218
Returns
₹19,218
(+19.22%)
Returns from Mimedx Group, Inc. Stock
₹13,613 (+13.61%)
Dollar Returns*
₹5,606 (+5.61%)
Based on 11 analysts
90.91%
Buy
9.09%
Hold
0.00%
Sell
Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Mimedx Group, Inc.. Average target price of $12.2
Get share price movements and forecasts by analysts on Mimedx Group, Inc..
What analysts predicted
46.64%UPSIDE
Target Price
$12.2
Current Price
$6.51
Analyzed by
11 Analysts
Target
$12.20
Mimedx Group, Inc. target price $12.2, a slight upside of 46.64% compared to current price of $6.51. According to 11 analysts rating.
Search interest for Mimedx Group, Inc. Stock has increased by 350% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:350% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 2 quarters, 88.20M → 98.60M (in $), with an average increase of 10.6% per quarter
Profit Spike
Netprofit is up for the last 2 quarters, 7.02M → 9.61M (in $), with an average increase of 27.0% per quarter
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 150.6% return, outperforming this stock by 25.3%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 64.1% return, outperforming this stock by 50.5%
Price Dip
In the last 7 days, MDXG stock has moved down by -10.3%
Organisation | Mimedx Group, Inc. |
Headquarters | 1775 West Oak Commons Court, NE, Marietta, GA, United States, 30062 |
Industry | Biotechnology |
CEO | Mr. Joseph H. Capper |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Douglas C. Rice CPA | Chief Financial Officer |
Ms. Ricci S. Whitlow | Executive VP & COO |
Mr. William F. Hulse IV | General Counsel & Chief Administrative Officer |
Ms. Kimberly Maersk-Moller | Chief Commercial Officer |
Dr. David H. Mason Jr., M.D. | Chief Medical Officer |
Mr. Joseph H. Capper | CEO & Director |
Mr. Matthew M. Notarianni | Head of Investor Relations |
Mr. Mark P. Graves | Senior VP & Chief Compliance Officer |
Ms. Hilary Dixon | Vice President of Investor Relations & Corporate Strategic Communications |
Ms. Kate Surdez | Chief Human Resources Officer |
Mimedx Group, Inc. share price today is $6.51 as on at the close of the market. Mimedx Group, Inc. share today touched a day high of $6.66 and a low of $6.45.
Mimedx Group, Inc. share touched a 52 week high of $10.14 on and a 52 week low of $5.59 on . Mimedx Group, Inc. stock price today i.e. is closed at $6.51,which is 35.80% down from its 52 week high and 16.56% up from its 52 week low.
Mimedx Group, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Mimedx Group, Inc. (MDXG) shares with as little as ₹88.635 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.35 in Mimedx Group, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Mimedx Group, Inc. share’s latest price of $6.51 as on October 14, 2025 at 1:29 am IST, you will get 1.5361 shares of Mimedx Group, Inc.. Learn more about
fractional shares .